tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Income Statement

Compare
256 Followers

Gain Therapeutics Income Statement

Last quarter (Q3 2024), Gain Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Gain Therapeutics's net income was $-4.49M. See Gain Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 55.18K$ 140.11K$ 164.99K$ 28.88K$ 41.30K
Gross Profit
$ -25.20K$ 75.94K$ -7.00M$ -2.23M$ 41.30K
Operating Expenses
$ 22.31M$ 17.92M$ 13.99M$ 3.51M$ 2.14M
Depreciation and Amortization
$ 83.58K$ 64.17K$ 15.48K$ 9.59K$ 2.57K
EBITDA
$ -22.17M$ -17.78M$ -13.82M$ -3.47M$ -2.10M
Operating Income
$ -22.25M$ -17.78M$ -13.83M$ -3.48M$ -2.10M
Other Income/Expenses
$ 64.89K$ 279.28K$ -60.42K$ -92.85K$ -86.22K
Pretax Income
$ -22.19M$ -17.50M$ -13.89M$ -3.57M$ -2.19M
Net Income
$ -22.27M$ -17.59M$ -13.89M$ -3.58M$ -2.19M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.71$ -1.48$ -1.37$ -0.30$ -0.18
Diluted EPS
$ -1.71$ -1.48$ -1.37$ -0.30$ -0.18
Weighted Average Shares Outstanding
13.01M 11.88M 10.17M 11.88M 11.88M
Weighted Average Shares Outstanding (Diluted)
13.01M 11.88M 10.17M 11.88M 11.88M
Currency in USD

Gain Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis